CCL Pharmaceuticals, a part of the CCL group, participated in the Centre of Excellence in Responsible Business(CERB) Sustainability Summit 2025 as an SDG Leader, underscoring its commitment to sustainable business practices and responsible growth in line with global development priorities.
CERB, an initiative of the Pakistan Business Council, brings together business leaders and sustainability experts to accelerate responsible business conduct. Through workshops, panels, and leadership programmes, CERB promotes climate action, environmental stewardship, inclusive workplaces, and other United Nations Sustainable Development Goals (SDGs).
CCL Pharmaceuticals’ participation as an SDG Leader reflects its strategic focus on SDG 13: Climate Action, recognising businesses that actively integrate sustainable practices into their operations and value chains. The summit provides a platform for organisations to share best practices, develop actionable insights, and strengthen their sustainability frameworks in a rapidly changing global landscape.
As part of the CCL group, CCL Pharmaceuticals operates with a long-term commitment to wellbeing and innovation, delivering high-quality healthcare solutions across multiple markets. Participation in the CERB Sustainability Summit reinforces the company’s broader role in advancing responsible business practices, both within its sector and the wider corporate community.
By engaging with CERB and other SDG Leaders, CCL Pharmaceuticals strengthens its capacity to contribute to sustainable development goals, aligning its operations with internationally recognised sustainability standards and demonstrating leadership in environmental and corporate governance.
